The importance of super-enhancers in the control of MYC expression in cancer is highlighted by the finding that inhibition of BRD4, a transcriptional activator that is particularly enriched in super-enhancers, is very effective in killing cancer cells because it leads to a strong decrease in MYC expression [60,61]. This evidence concerns the gene MYC and cancer.